Radiotherapy for Malignant Astrocytomas in the Elderly
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00430911 |
Recruitment Status :
Completed
First Posted : February 2, 2007
Last Update Posted : February 2, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Primary Brain Tumor Anaplastic Astrocytoma Glioblastoma Multiforme | Drug: Radiotherapy | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Study Start Date : | February 2001 |

- Survival
- Progression free survival
- Quality of life
- Cognitive functions

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 70 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed
- Brain CT scan or MRI within 28 days before surgery
- Age: 70 years or older
- Karnofsky performance status, 70 or more.
- Life expectancy over 12 weeks
- Informed consent
Exclusion Criteria:
- Brain radiotherapy
- Chemotherapy
- Severe systemic disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00430911
France | |
Hôpital de la Salpêtrière | |
Paris, Ile de France, France, 75013 |
Principal Investigator: | jean-yves Delattre, MD | Assistance Publique - Hôpitaux de Paris | |
Principal Investigator: | Florence Keime-Guibert, MD | Assitance Publique-Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT00430911 |
Other Study ID Numbers: |
PHRC, P000502 AOM 98071 |
First Posted: | February 2, 2007 Key Record Dates |
Last Update Posted: | February 2, 2007 |
Last Verified: | January 2007 |
malignant gliomas |
Glioblastoma Brain Neoplasms Astrocytoma Glioma Neoplasms, Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms |
Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site Brain Diseases Central Nervous System Diseases Nervous System Diseases |